Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
CompletedOBSERVATIONAL
Enrollment
566
Participants
Timeline
Start Date
November 30, 2011
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Conditions
Ankylosing SpondylitisPsoriatic Arthritis
All Listed Sponsors
lead
AbbVie (prior sponsor, Abbott)
INDUSTRY
NCT01474876 - Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis | Biotech Hunter | Biotech Hunter